ONESOURCEBSEOnesource Specialty Pharma LtdMediumPositive
Announced Sat, 16 May · 13:13 IST

We wish to inform that the Government of Karnataka has accorded in-principle approval for the application submitted by the Company for Unit-II expansion project under the Karnataka Industrial ....

Capex & Operations View source PDF

ONESOURCE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.9%1-day move
₹1833.00
prior close
₹1825.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+2.0+3.9+2.7+0.9+2.2+1.7-0.4-1.8-2.8-6.6-10.8-8.1
Up moveDown movePending
AI summary

The Government of Karnataka has granted in-principle approval for Onesource Specialty Pharma's Unit II expansion project at its Obadenahalli facility in Doddaballapur Taluk, Bengaluru Rural District. The approval was issued via Government Order No. CI 120 SPI 2026 dated May 12, 2026, and received by the company on May 15, 2026. The project falls under the Karnataka Industrial Policy (KIP) 2025-30 and was cleared by the 67th State High Level Clearance Committee on April 13, 2026. The company says the expansion is a significant step in its growth strategy to boost manufacturing capacity for global partners. No specific investment amount or capex figure was disclosed in the filing.

Likely market impact

The approval opens the door to incentives and concessions under KIP 2025-30, potentially reducing the cost burden of the expansion. The announcement is positive for long-term growth prospects, though no immediate financial impact can be assessed without capex numbers.